Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferry Ossendorp

Showing results (121-130 of 159) with videos related to

Pageof 16
Sort By:
Molecular Immunology|November 26, 2008
Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cellsSelina Khan, Jimmy J Weterings, Cedrik M Britten, et al.
Nanoscale|October 18, 2016
Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bondsDandan Li, Feilong Sun, Meriem Bourajjaj, et al.
Traffic (Copenhagen, Denmark)|August 18, 2009
MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathwaysSonja I Buschow, Esther N M Nolte-'t Hoen, Guillaume van Niel, et al.
Bioconjugate Chemistry|March 14, 2019
Dual Synthetic Peptide Conjugate Vaccine Simultaneously Triggers TLR2 and NOD2 and Activates Human Dendritic CellsGijs G Zom, Marian M J H P Willems, Nico J Meeuwenoord, et al.
Immunology|September 26, 2006
Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivoJudith M H de Jong, Danita H Schuurhuis, Andreea Ioan-Facsinay, et al.
European Journal of Immunology|June 23, 2009
DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) TregWanda G H Han, Danita H Schuurhuis, Nathalie Fu, et al.
Journal for Immunotherapy of Cancer|December 14, 2018
Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradicationGijs G Zom, Marian M J H P Willems, Selina Khan, et al.
Journal of Medicinal Chemistry|July 15, 2014
N-tetradecylcarbamyl lipopeptides as novel agonists for Toll-like receptor 2Marian M J H P Willems, Gijs G Zom, Selina Khan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cellsFerry Ossendorp, Nathalie Fu, Marcel Camps, et al.
Blood|March 29, 2003
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoproteinEric Spierings, Anthony G Brickner, Jennifer A Caldwell, et al.
Pageof 16

Showing results (121-130 of 159) with videos related to

Sort By:
Pageof 16
Molecular Immunology|November 26, 2008
Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cellsSelina Khan, Jimmy J Weterings, Cedrik M Britten, et al.
Nanoscale|October 18, 2016
Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bondsDandan Li, Feilong Sun, Meriem Bourajjaj, et al.
Traffic (Copenhagen, Denmark)|August 18, 2009
MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathwaysSonja I Buschow, Esther N M Nolte-'t Hoen, Guillaume van Niel, et al.
Bioconjugate Chemistry|March 14, 2019
Dual Synthetic Peptide Conjugate Vaccine Simultaneously Triggers TLR2 and NOD2 and Activates Human Dendritic CellsGijs G Zom, Marian M J H P Willems, Nico J Meeuwenoord, et al.
Immunology|September 26, 2006
Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivoJudith M H de Jong, Danita H Schuurhuis, Andreea Ioan-Facsinay, et al.
European Journal of Immunology|June 23, 2009
DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) TregWanda G H Han, Danita H Schuurhuis, Nathalie Fu, et al.
Journal for Immunotherapy of Cancer|December 14, 2018
Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradicationGijs G Zom, Marian M J H P Willems, Selina Khan, et al.
Journal of Medicinal Chemistry|July 15, 2014
N-tetradecylcarbamyl lipopeptides as novel agonists for Toll-like receptor 2Marian M J H P Willems, Gijs G Zom, Selina Khan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cellsFerry Ossendorp, Nathalie Fu, Marcel Camps, et al.
Blood|March 29, 2003
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoproteinEric Spierings, Anthony G Brickner, Jennifer A Caldwell, et al.
Pageof 16